Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
基本信息
- 批准号:10493394
- 负责人:
- 金额:$ 17.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-09-29
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
There is a critical need to grow and strengthen the pipeline of physician scientists who have expertise in
sociomedical and behavioral research and are dedicated to addressing the nation's challenges posed by
Alzheimer's disease and related dementias (ADRD). The Indiana ADRD Medical Scientist Training Program
(IADRD MSTP) was conceived to meet this need. This application leverages the strengths of our robust
infrastructure of ADRD research, world class graduate training programs in medical neurosciences and
sociology, and our existing MD-PhD program at Indiana University School of Medicine to train the next
generation of physician scientists who will become leaders in ADRD research. The Aims of the IADRD MSTP
are: 1) To recruit and train a competitive pool of diverse students who espouse a strong interest and
commitment to social and behavioral research and patient care focused on Alzheimer's disease and related
dementias; 2) To engage MD-PhD students early in mentored sociomedical and behavioral research that
integrates Indiana University's systems-based medical training curriculum with our cutting edge ADRD
research that reinforces commitment and minimizes attrition of physician-scientists ADRD; and 3) To graduate
students with dual MD-PhD degrees with strong methodological training in social and behavioral science and
experts in ADRD who will be competitive for residency and be successful independent investigators at the best
academic medical centers nationwide. To achieve these aims, we will develop an MD-PhD training program
with rigorous didactic training in social, behavioral, and clinical research methods, with flexibility to allow
students to focus their effort on one methodological area of interest; early initiation of ADRD research
experiences with multidisciplinary teams of mentors and advisors; and the provision of educational experiences
that enhance students' abilities to become independent researchers. The IADRD MSPT will leverage the
existing ADRD sociomedical, behavioral and clinical research infrastructure at Indiana University that has a
current portfolio of over $408 million in funded research and our internationally recognized and ranked doctoral
programs in Medical Neurosciences and Sociology to identify, train, mentor, and successfully graduate two
MD-PhD students per year. The program will be administratively successful with both its own independent
group of faculty advisors and its organizational integration with the existing successful MD-PhD program within
the IUSM that has an eleven-year track record of success and is supported by the NIH, Dean's office, Indiana
CTSI, and a dedicated $10M endowment to the program.
在拥有专业知识的医师科学家的渠道中,迫切需要增长和加强渠道
社会医学和行为研究,致力于应对国家的挑战
阿尔茨海默氏病和相关痴呆症(ADRD)。印第安纳州ADRD医学科学家培训计划
(IADRD MSTP)被构想以满足这一需求。该应用程序利用了我们强大的优势
ADRD研究的基础设施,医学神经科学领域的世界一流研究生培训计划
社会学,以及我们在印第安纳大学医学院现有的MD-PHD计划训练下一个
一代医师科学家将成为ADRD研究的领导者。 IADRD MSTP的目的
是:1)招募和培训一群竞争性的不同学生,这些学生拥护强烈的兴趣和
致力于社会和行为研究和患者护理,重点是阿尔茨海默氏病及相关
痴呆症; 2)早期让MD-PHD学生参与指导的社会医学和行为研究
将印第安纳大学基于系统的医学培训课程与我们的尖端ADRD集成
加强承诺并最大程度地减少医师科学家ADRD的损耗的研究; 3)毕业
具有双重MD-PHD学位的学生在社会和行为科学方面具有强大的方法学培训,
ADRD的专家将在居住中竞争竞争,并取得成功的独立研究者
全国学术医疗中心。为了实现这些目标,我们将制定一个MD-PHD培训计划
通过在社会,行为和临床研究方法中进行严格的教学培训,并具有灵活性
学生将精力集中在一个感兴趣的方法论领域; ADRD研究的早期开始
由导师和顾问组成的多学科团队的经验;以及提供教育经验
这增强了学生成为独立研究人员的能力。 IADRD MSPT将利用
印第安纳大学现有的ADRD社会医学,行为和临床研究基础设施
当前的投资组合超过4.08亿美元的资助研究,我们的国际认可和排名博士
医学神经科学和社会学方案,以识别,培训,指导和成功毕业两个
MD-PHD学生每年。该计划将在行政上取得成功,这是其自己的独立
一组教师顾问及其与现有成功的MD-PHD计划的组织一体化
IUSM拥有11年成功的记录,并得到了印第安纳州院长办公室的支持
CTSI,并为该计划提供了1000万美元的捐款。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER M CALLAHAN其他文献
CHRISTOPHER M CALLAHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER M CALLAHAN', 18)}}的其他基金
Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
- 批准号:
10687172 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
Training the Next Generation of Social and Behavioral Physician-Scientists in ADRD: The Indiana ADRD Medical Scientist Training Program
培训 ADRD 领域的下一代社会和行为医师科学家:印第安纳州 ADRD 医学科学家培训计划
- 批准号:
10340047 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
Alzheimer's Disease Multiple Intervention Trial - ADMIT
阿尔茨海默病多重干预试验 - ADMIT
- 批准号:
8293129 - 财政年份:2010
- 资助金额:
$ 17.5万 - 项目类别:
Alzheimer's Disease Multiple Intervention Trial - ADMIT
阿尔茨海默病多重干预试验 - ADMIT
- 批准号:
7987916 - 财政年份:2010
- 资助金额:
$ 17.5万 - 项目类别:
Alzheimer's Disease Multiple Intervention Trial - ADMIT
阿尔茨海默病多重干预试验 - ADMIT
- 批准号:
8494492 - 财政年份:2010
- 资助金额:
$ 17.5万 - 项目类别:
Alzheimer's Disease Multiple Intervention Trial - ADMIT
阿尔茨海默病多重干预试验 - ADMIT
- 批准号:
8111085 - 财政年份:2010
- 资助金额:
$ 17.5万 - 项目类别:
相似海外基金
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 17.5万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 17.5万 - 项目类别:
Behavioral and physiological measurements of hearing in mouse models of Alzheimer's Disease
阿尔茨海默病小鼠模型听力的行为和生理测量
- 批准号:
10647340 - 财政年份:2023
- 资助金额:
$ 17.5万 - 项目类别:
Role of Sarm1 in TBI-accentuated C9orf72 Frontotemporal Dementia
Sarm1 在 TBI 加重的 C9orf72 额颞叶痴呆中的作用
- 批准号:
10646932 - 财政年份:2023
- 资助金额:
$ 17.5万 - 项目类别:
Mechanisms underlying Sex differences in Cerebral Amyloid Angiopathy: The Fibrin-Microglia Crosstalk
脑淀粉样血管病性别差异的潜在机制:纤维蛋白-小胶质细胞串扰
- 批准号:
10662862 - 财政年份:2023
- 资助金额:
$ 17.5万 - 项目类别: